ArticleMolecular cancer2014

Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.

Nathaniel Weygant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.